Dr. Lindsey Draper is an Adjunct Instructor in the Department of Medicine at the University of California, San Francisco, where she specializes in the care of patients with ovarian cancer. As a physician-scientist in the Roybal Laboratory, she conducts research at the intersection of immunology and synthetic biology to develop novel immunotherapies for patients with ovarian cancer and other aggressive solid tumors. Her work focuses on genetically enhancing tumor-infiltrating lymphocytes (TILs) to overcome mechanisms of resistance in ovarian cancer, with the goal of creating safer and more effective treatment options.

Dr. Draper brings extensive expertise in immunotherapy, including her prior work in the laboratory of Dr. Steven A. Rosenberg at the National Cancer Institute, where she contributed to efforts in TIL therapy and T-cell receptor discovery for HPV-associated cancers. This work led to multiple clinical trials that, for the first time, demonstrated that cellular therapeutics can induce responses in patients with epithelial malignancies.